FSM Wealth Advisors LLC Purchases New Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

FSM Wealth Advisors LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to its most recent filing with the SEC. The firm acquired 507 shares of the medical equipment provider’s stock, valued at approximately $249,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Legacy CG LLC bought a new stake in Intuitive Surgical during the 3rd quarter worth about $3,251,000. Impax Asset Management Group plc raised its stake in shares of Intuitive Surgical by 43.9% during the third quarter. Impax Asset Management Group plc now owns 5,167 shares of the medical equipment provider’s stock worth $2,538,000 after buying an additional 1,577 shares during the last quarter. Hazlett Burt & Watson Inc. grew its holdings in Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after acquiring an additional 20 shares during the period. Quintet Private Bank Europe S.A. raised its position in shares of Intuitive Surgical by 1.1% during the 3rd quarter. Quintet Private Bank Europe S.A. now owns 66,534 shares of the medical equipment provider’s stock valued at $32,686,000 after acquiring an additional 708 shares during the last quarter. Finally, World Equity Group Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $205,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now directly owns 821 shares in the company, valued at approximately $402,519.88. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now owns 821 shares of the company’s stock, valued at approximately $402,519.88. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 68,246 shares of company stock valued at $33,839,308. 0.80% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on ISRG. Raymond James boosted their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Piper Sandler reiterated an “overweight” rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Mizuho increased their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Truist Financial lifted their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. Finally, JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Price Performance

ISRG opened at $507.42 on Tuesday. The company’s 50 day moving average price is $490.97 and its two-hundred day moving average price is $448.54. Intuitive Surgical, Inc. has a fifty-two week low of $269.49 and a fifty-two week high of $523.34. The firm has a market capitalization of $180.73 billion, a price-to-earnings ratio of 81.58, a PEG ratio of 4.98 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.